These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34108104)

  • 21. Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy.
    Chen KW; Zieglmayer P; Zieglmayer R; Lemell P; Horak F; Bunu CP; Valenta R; Vrtala S
    J Allergy Clin Immunol; 2019 Mar; 143(3):1248-1252.e12. PubMed ID: 30445063
    [No Abstract]   [Full Text] [Related]  

  • 22. [House dust mite allergy: myths and realities].
    Bouton C; Ducommun J
    Rev Med Suisse; 2009 Apr; 5(199):832-6. PubMed ID: 19441749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-life house dust mite allergens, childhood mite sensitization, and respiratory outcomes.
    Casas L; Sunyer J; Tischer C; Gehring U; Wickman M; Garcia-Esteban R; Lehmann I; Kull I; Reich A; Lau S; Wijga A; Antó JM; Nawrot TS; Heinrich J; Keil T; Torrent M
    Allergy; 2015 Jul; 70(7):820-7. PubMed ID: 25858551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in the development of specific immunotherapies for house dust mite allergies.
    Moingeon P
    Expert Rev Vaccines; 2014 Dec; 13(12):1463-73. PubMed ID: 25187166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of house dust mite immunotherapy.
    Lipworth B
    J Allergy Clin Immunol; 2015 Jan; 135(1):288. PubMed ID: 25441292
    [No Abstract]   [Full Text] [Related]  

  • 26. Dual sublingual immunotherapy with Japanese Cedar Pollen droplets and House Dust Mite tablets.
    Matsuoka T; Igarashi S; Kuroda Y; Fukano C; Natsui K; Doi-Ohashi K; Masuyama K
    Allergol Int; 2019 Oct; 68(4):533-535. PubMed ID: 30962053
    [No Abstract]   [Full Text] [Related]  

  • 27. Geography of house dust mite allergens.
    Thomas WR
    Asian Pac J Allergy Immunol; 2010 Dec; 28(4):211-24. PubMed ID: 21337903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mite allergens.
    Caraballo L
    Expert Rev Clin Immunol; 2017 Apr; 13(4):297-299. PubMed ID: 28162009
    [No Abstract]   [Full Text] [Related]  

  • 29. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy.
    Aarestrup MF; Aarestrup PF; de Andrade MS; Aarestrup BJV; Nagato AC; Aarestrup FM
    Int J Immunopathol Pharmacol; 2021; 35():20587384211015528. PubMed ID: 33985377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.
    Canonica GW; Virchow JC; Zieglmayer P; Ljørring C; Smith IM; Mosbech H
    Expert Rev Clin Immunol; 2016 Aug; 12(8):805-15. PubMed ID: 27322777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of house dust mite allergy.
    Yang L; Zhu R
    Hum Vaccin Immunother; 2017 Oct; 13(10):2390-2396. PubMed ID: 28853977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
    Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
    Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged effect of allergen sublingual immunotherapy for house dust mites in elderly patients.
    Bozek A; Starczewska-Dymek L; Jarzab J
    Ann Allergy Asthma Immunol; 2017 Jul; 119(1):77-82. PubMed ID: 28668244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific immunoglobulin E and immunoglobulin G4 toward major allergens of house-dust mite during allergen-specific immunotherapy.
    Chen J; Zhou Y; Wang Y; Zheng Y; Lai X; Westermann-Clark E; Cho SH; Kong W
    Am J Rhinol Allergy; 2017 May; 31(3):156-160. PubMed ID: 28490399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
    Du X; Shu C; Xu G; Ma M; Song H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in allergen content in sublingual allergen immunotherapy with house dust mites.
    Moreno Benítez F; Espinazo Romeu M; Letrán Camacho A; Mas S; García-Cózar FJ; Tabar AI
    Allergy; 2015 Nov; 70(11):1413-20. PubMed ID: 26185961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The best allergen immunotherapy choice for mite allergic patients.
    Ciprandi G; Incorvaia C; Masieri S; Buttafava S; Frati F
    Expert Rev Clin Immunol; 2016 Jun; 12(6):603-4. PubMed ID: 26950287
    [No Abstract]   [Full Text] [Related]  

  • 40. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care.
    de Bot CM; Moed H; Berger MY; Röder E; Hop WC; de Groot H; de Jongste JC; van Wijk RG; Bindels PJ; van der Wouden JC
    Pediatr Allergy Immunol; 2012 Mar; 23(2):150-8. PubMed ID: 22017365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.